Sign In
Buy FWBI
$2.96
+0 (+0%)
At Close: Aug 15, 2024
CORRECTION: Fold Rolls Out New Bitcoin Rewards Credit Card
09:53am, Wednesday, 27'th May 2026
A Simple, Mobile-First Way to Earn Bitcoin Rewards On Qualifying Purchases – All Seamlessly Integrated into the Fold App A Simple, Mobile-First Way to Earn Bitcoin Rewards On Qualifying Purchases �
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market
07:55am, Friday, 10'th May 2024
BOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializin
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month
07:00am, Thursday, 09'th May 2024
BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializin
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
07:00am, Wednesday, 24'th Apr 2024
Paper highlights findings on impact of a gluten-containing diet on serologic status in celiac disease Paper highlights findings on impact of a gluten-containing diet on serologic status in celiac dise
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
07:00am, Wednesday, 17'th Apr 2024
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializ
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
07:00am, Wednesday, 17'th Apr 2024
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializ
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference
07:00am, Monday, 15'th Apr 2024
BOCA RATON, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializ
Here's Why First Wave BioPharma (FWBI) Is a Great 'Buy the Bottom' Stock Now
10:56am, Friday, 05'th Apr 2024
After losing some value lately, a hammer chart pattern has been formed for First Wave BioPharma (FWBI), indicating that the stock has found support. This, combined with an upward trend in earnings est
First Wave BioPharma (FWBI) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 27'th Mar 2024
First Wave BioPharma (FWBI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Poster presentations to highlight new quantitative and serologic diagnostic methods for Celiac Disease detection and determination of intestinal mucosal health
Why Is First Wave BioPharma (FWBI) Stock Up Today?
08:05am, Thursday, 14'th Mar 2024
First Wave BioPharma (NASDAQ: FWBI ) stock is heading higher on Thursday after the clinical-stage biopharmaceutical company completed its business combination with ImmunogenX. First Wave BioPharma us
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease James Sapirstein, Chairman and Chief Executive Officer, to continue leading First Wave BioPharma;
First Wave BioPharma to Participate In ‘Fireside Chat' at the 36th Annual Roth Conference
07:00am, Tuesday, 05'th Mar 2024
BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializ
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
07:00am, Tuesday, 13'th Feb 2024
BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializi
First Wave BioPharma to Present at the DealFlow MicroCap Conference
07:00am, Tuesday, 23'rd Jan 2024
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializi
